Skip to content
Recall Observatory FDA recall evidence

Drug product

Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-Davis, Division of Pfizer Inc., NDC 0071-0418-13

D-1049-2022

April 13, 2022

Class II

Product summary

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Event
Event 89646
Status
Terminated
Classification
Class II
Quantity
1 carton/4 bottles per carton/25 tablets per bottle
Official record key
drug-enforcement:D-1049-2022

Official wording

Reason: cGMP deviations: Temperature abuse

Code information: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.

Distribution pattern: USA nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations